Presentations

Presentations

The IX INGID Meeting in Instanbul, 2010

• The value of a nursing review of the PID patient on home therapy with Immunoglobulin - Caroline O’Grady
• Extended follow up of home therapy with hyaluronidase-facilitated subcutaneous immunoglobulin (fSCIg) - Emma Knight
• Global care of a child with SCID in the pediatric Immuno-Hematology Rhumatologie unit - Pr A. Fischer unit
• Disorders of the Immune Stem - Gretchen Vaughn
• Implementing a Patient Led Support Group for Patients with Immunodeficiency at Papworth Hospital, Cambridge - Karen Henderson
• The Normal Immune System - Dr Peter Vickers
• The Effects of the Immune System on Pregnancy - Dr Peter Vickers
• The Role Of Nurses In Health Care In Turkey - Mukaddes Can Turk
• Presentations of the INGID Board:
  • Educational Day
  • Overview of programme
  • Closing
  • Opening
  • Nursing Care Protocol for Patients with Primary Immunodeficiencies
  • Presentation from the Board
  • African Society ID Global Leaders Meeting PID Call to Action
  • Why Istanbul?
  • Communications

How Did It Happen? An Exploration Of Genetics And Immunodeficiencies

• Dr Peter Vickers, University Of Hertfordshire
  Presentation
  PowerPoint presentation (479 KB)
  

X-Linked Agammaglobulinemia

• Versailles, France October 22, 2004 INGID
  Presentation
  PowerPoint presentation (68 KB)

The VIII INGID Meeting in 's-Hertgoenbosch, 2008

• Bug & Superbug (with apologies to George Bernard Shaw)
• Immunology nursing in Auckland
• Reduced conditioning for BMT in children with PID

The VII INGID Meeting in Budapest, October 2006

• Alienation & PTSD in children and families with SCID
• Education of patients with primary hypogammaglobulinemia for S/C Ig self-administration
• The ESID online database
• Gene Therapy or Bone Marrow Transplant?
• Gene Therapy Trials for PID: A Nursing Perspective
• Prognostic Factors for Improved Health-Related Quality of Life in Children and Adults With Primary Antibody Deficiencies
• Mannan-Binding Lectin: What do we Know? Implications for Nurses and Patients with PID
• How much gammaglobulin?
• Subcutaneous ImmunoglobulinTherapy A New Way of Permanent Treatment in Primary Immunodeficiencies
• What is patient satisfaction and what can we do about it?

Bookmark this site